|
Post by agedhippie on May 5, 2017 11:35:53 GMT -5
Even the mildest T2 diabetic needs to monitor blood sugar more than once per day. Upon awakening, bedtime and at least once or twice during the day. Again, I don't think 1 strip a day is anywhere near correct for the vast majority of even T2 diabetics. Sorry. Yes if you are not on any sort of insulin or hypo causing medication you typically get limited. And it is not near enough to manage Type 2. This is a topic of some heartache on various diabetes boards among Type 2s. Certainly used to be there was a limit of 50 strips per month but if that has changed it's good news.
|
|
|
Post by alethea on May 5, 2017 11:45:37 GMT -5
Even the mildest T2 diabetic needs to monitor blood sugar more than once per day. Upon awakening, bedtime and at least once or twice during the day. Again, I don't think 1 strip a day is anywhere near correct for the vast majority of even T2 diabetics. Sorry. Yes if you are not on any sort of insulin or hypo causing medication you typically get limited. And it is not near enough to manage Type 2. This is a topic of some heartache on various diabetes boards among Type 2s. Certainly used to be there was a limit of 50 strips per month but if that has changed it's good news. I've been Type 2 (diagnosed) for 14 years and I've never been limited to less than a box of 100 per month, even with lousy, crummy insurance. And for most of it I was NOT prescribed insulin. Mostly just Metformin for most of that time. One strip per day is simply not true for 95% of even T2 diabetics, period.
|
|
|
Post by derek2 on May 5, 2017 11:59:37 GMT -5
Sorry. Yes if you are not on any sort of insulin or hypo causing medication you typically get limited. And it is not near enough to manage Type 2. This is a topic of some heartache on various diabetes boards among Type 2s. Certainly used to be there was a limit of 50 strips per month but if that has changed it's good news. I've been Type 2 (diagnosed) for 14 years and I've never been limited to less than a box of 100 per month, even with lousy, crummy insurance. And for most of it I was NOT prescribed insulin. Mostly just Metformin for most of that time. One strip per day is simply not true for 95% of even T2 diabetics, period. Says you and says me, but payers often take a different view "Limiting reimbursement for blood glucose test strips does not harm patients and reduces costs" www.stmichaelshospital.com/media/detail.php?source=hospital_news/2016/1107www.iddt.org/here-to-help/iddt-campaigning/limiting-availability-of-blood-glucose-test-stripswww.health.gov.on.ca/en/pro/programs/drugs/teststrips/bg_teststrips.aspxThe Ontario Public Drug Program coverage is egregious - 200 strips per year if you aren't on insulin. Diabetes Treatment Category Number of BGTS allowed within a 365-day period Patients managing diabetes with insulin 3,000 Patients managing diabetes with anti-diabetes medication with high risk of causing hypoglycemia 400 Patients managing diabetes using anti-diabetes medication with low risk of causing hypoglycemia 200 Patients managing diabetes through diet/lifestyle therapy only (no insulin or anti-diabetes medications) 200 So although we would all agree that testing multiple times a day, not everybody is so lucky.
|
|
|
Post by alethea on May 5, 2017 12:08:59 GMT -5
Derek, you are T2. How many strips per day do you get? If you personally know other T2's, how many do they get?
I'm not arguing medical efficacy, I'm very simply saying that I believe there are very, very few that do not receive more than one strip per day.
Do you know anyone?
|
|
|
Post by derek2 on May 5, 2017 12:39:35 GMT -5
Derek, you are T2. How many strips per day do you get? If you personally know other T2's, how many do they get? I'm not arguing medical efficacy, I'm very simply saying that I believe there are very, very few that do not receive more than one strip per day. Do you know anyone? This is the only place I talk about my diabetes publicly, so I'm kind of useless when it comes to knowing what my friends face medical-wise. That said, I've never had trouble getting the number of strips that I need (I test 4X per day). I was throwing out a counter-argument based on some stuff that I've read but not experienced. I guess it would fall into the "take it for what it's worth" category.
|
|
|
Post by alethea on May 5, 2017 12:48:03 GMT -5
I too am covered to test 4 x per day. And from experience I know that I can refill my box of 100 on the 23rd day following the date of my last script. I always need it ASAP.
Incidentally WITHOUT insurance a box of 100 cost about $170 per month. Same strips (basically) cost about $40 per box 14 years ago.
Thanks for the response.
|
|
|
Post by jlaw277 on May 5, 2017 13:29:24 GMT -5
The planned collaboration will include three consumer-focused areas: 1. Access, Cost Savings and Convenience initiatives, intended to simplify the complexity of starting and staying on mealtime insulin. 2. Customized Coaching and Engagement designed to help people on Afrezza achieve the American Diabetes Association (ADA) recommendation of an A1C goal of less than 7%. 3. Design innovation around packaging and exploration of a reusable Afrezza Inhaler with integrated Bluetooth technology.
---
"Against a backdrop of soaring insulin costs, this proposed collaboration is an essential step in the right direction," said Jeff Dachis, CEO and Founder of One Step. "One Drop began with the goal of bringing affordable, accessible diabetes care to everyone living with diabetes worldwide. Through this partnership with MannKind, we will continue to work tirelessly to empower everyone with diabetes to achieve better health outcomes through the use of modern delivery methods that reduce the burden of diabetes management and increase engagement in self-care." "The complexity and conflicting incentives of the United States healthcare system are not aligned to help people with diabetes on insulin achieve optimal outcomes, as we see that almost seven out of ten people on mealtime insulin are not at the ADA goal of <7% A1C," said Michael Castagna, Chief Commercial Officer of MannKind Corporation. "Even though injectable insulins have been available for decades, 20% of users regularly skip injections. We intend to empower people with diabetes to take charge of their health by trying something different."
"We believe that diabetes care as a fully integrated digital service is the only way that we are going to bend the cost curve for payers and providers, while at the same time delivering evidence-based health outcomes that can scale," continued Dachis. "Working with an innovator like MannKind, with a clinically effective, non-invasive inhaled mealtime insulin product, offers up an exciting opportunity to further our mission of relentlessly improving the lives of everyone with diabetes and a smartphone."
==== This partnership is starting to look even more interesting. One Drop was not solely funded by Dachis with his Razorfish money but instead had an interesting round of Angel money in 2015 from: Philip Kaplan, Jason Calacanis, Jerry Neumann, Alex Payne from Twitter, and Charlie Martin from Vanguard Health (http://martinventures.com/about/our-team/) These are smart sophisticated investors. I don't know their role now or what the current ownership looks like but it is highly unlikely that these guys (with Dachis) would knowingly partner with a company at death's door. It adds a little credibility to the idea that Matt P might have things more under control than it might appear on the surface. Still dark days but this provides a small ray of light. techcrunch.com/2015/04/21/razorfishs-jeff-dachis-launches-one-drop-an-app-for-diabetics-to-log-and-share-info-with-each-other/ Plus it is impressive how Dachis has built the company from being solely an app to an app plus hardware.
|
|
|
Post by scoy on May 5, 2017 14:16:15 GMT -5
I wish the collaboration had been/would be one free month of one drop with an afrezza prescription. Some number of people are using the OneDrop system and buying insulin all without a doctor and without a prescription. You can see it in the comments as you read through the site. Pennsylvania: In PA pharmacies are required to sell cheap insulin over the counter with. no prescription required. In my area most carry Novolin R at various prices but very reduced prices. Mine is $25 per vial. Missouri: At Walmart in MO reli-on insulin (also made by Lilly) is over the counter and costs < $25. onedrop.today/blog/2016/10/28/insulin-for-less/
|
|
|
Post by sportsrancho on May 5, 2017 16:25:26 GMT -5
|
|
|
Post by agedhippie on May 5, 2017 17:47:13 GMT -5
I too am covered to test 4 x per day. And from experience I know that I can refill my box of 100 on the 23rd day following the date of my last script. I always need it ASAP. Incidentally WITHOUT insurance a box of 100 cost about $170 per month. Same strips (basically) cost about $40 per box 14 years ago. Thanks for the response. Here you go. This is from the medicare web site ( Medicare’s Coverage of Diabetes Supplies & Services): If you can get your doctor to write a letter of medical necessity then you can get more. There is a parallel to Afrezza here in that some doctor will but most won't so you have to go doctor shopping to find a compliant doctor. The usual argument doctors use is that it's what the guidelines say you need so you are overtesting (don't get me started) if you use more. If you need to buy strips then the usual advice is the Walmart meters. The ReliOn Prime strips are $17.88 per 100, and the ReliOn Ultima are $35.88 per 100. The Prime is produced by Arkray and the Ultima by Abbott (it's a Precision Exceed with the ketone function disabled). The Ultima is the better meter by far and I use it when I want a slim-line meter as the strips are foil wrapped rather then in a canister.
|
|
|
Post by falconquest on May 7, 2017 6:28:18 GMT -5
Wow! If you haven't seen Jeff Dachis in action check out the Milan video in this link. onedrop.today/about/press/This is a man with passion and to me someone who understands that technology is about to change the way healthcare is administered, especially for those with chronic diseases. He's right about big pharma. I can certainly see why Mannkind partnered with One Drop, they are both disruptive technologies and nothing is better for staying "in range" than Afrezza. My sentiments about Mannkind as an investment may be about to change. The question is, can the turn around happen in time to avert the coming cash crisis?
|
|
|
Post by sportsrancho on May 7, 2017 7:19:11 GMT -5
Wow! If you haven't seen Jeff Dachis in action check out the Milan video in this link. onedrop.today/about/press/This is a man with passion and to me someone who understands that technology is about to change the way healthcare is administered, especially for those with chronic diseases. He's right about big pharma. I can certainly see why Mannkind partnered with One Drop, they are both disruptive technologies and nothing is better for staying "in range" than Afrezza. My sentiments about Mannkind as an investment may be about to change. The question is, can the turn around happen in time to avert the coming cash crisis? Thanks that was great! And I'm excited you're excited! I also get a sense that management is excited:-) So many dots being connected. And how long before Jeff, Charles, and many other key people are using Afrezza?
|
|
|
Post by careful2invest on May 7, 2017 7:21:03 GMT -5
Wow! If you haven't seen Jeff Dachis in action check out the Milan video in this link. onedrop.today/about/press/This is a man with passion and to me someone who understands that technology is about to change the way healthcare is administered, especially for those with chronic diseases. He's right about big pharma. I can certainly see why Mannkind partnered with One Drop, they are both disruptive technologies and nothing is better for staying "in range" than Afrezza. My sentiments about Mannkind as an investment may be about to change. The question is, can the turn around happen in time to avert the coming cash crisis? Curious to know if the founder of One Drop is an actual user of AFREZZA? To gain the personal support of AFREZZA by him and others like him in the field would be extremely beneficial to the brand. We already know that the head of the JDRF uses AFREZZA and swears by it. Imagine having these individuals stating that in all of their presentations. The tide may be changing... GLTA!
|
|
|
Post by promann on May 7, 2017 7:32:56 GMT -5
Wow! If you haven't seen Jeff Dachis in action check out the Milan video in this link. onedrop.today/about/press/This is a man with passion and to me someone who understands that technology is about to change the way healthcare is administered, especially for those with chronic diseases. He's right about big pharma. I can certainly see why Mannkind partnered with One Drop, they are both disruptive technologies and nothing is better for staying "in range" than Afrezza. My sentiments about Mannkind as an investment may be about to change. The question is, can the turn around happen in time to avert the coming cash crisis? Curious to know if the founder of One Drop is an actual user of AFREZZA? To gain the personal support of AFREZZA by him and others like him in the field would be extremely beneficial to the brand. We already know that the head of the JDRF uses AFREZZA and swears by it. Imagine having these individuals stating that in all of their presentations. The tide may be changing... GLTA! Careful, I'm sure he is using Afrezza although I have no evidence of it but it would make complete sense . Given the recent news of Collaboration he must be seeing real time results using his technology with one drop
|
|
|
Post by careful2invest on May 7, 2017 7:53:38 GMT -5
Curious to know if the founder of One Drop is an actual user of AFREZZA? To gain the personal support of AFREZZA by him and others like him in the field would be extremely beneficial to the brand. We already know that the head of the JDRF uses AFREZZA and swears by it. Imagine having these individuals stating that in all of their presentations. The tide may be changing... GLTA! Careful, I'm sure he is using Afrezza although I have no evidence of it but it would make complete sense . Given the recent news of Collaboration he must be seeing real time results using his technology with one drop One would think that he is using AFREZZA, but I will be looking forward to hearing future presentations from him stating that he is. When heads of Diabetic treatment related companies begin using AFREZZA themselves and make it public, that will move mountains. Hopefully in time so MNKD can survive! GLTA!
|
|